nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanoma
|
Gerard, Béatrice |
|
1993 |
29 |
Supplement 1 |
p. 711-719 9 p. |
artikel |
2 |
Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma
|
Karakousis, C. |
|
1993 |
29 |
Supplement 1 |
p. 1831-1835 5 p. |
artikel |
3 |
Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study
|
Bakkevold, K.E. |
|
1993 |
29 |
Supplement 1 |
p. 698-703 6 p. |
artikel |
4 |
Adjuvant systemic therapy in breast cancer
|
Mouridsen, H.T. |
|
1993 |
29 |
Supplement 1 |
p. 595-598 4 p. |
artikel |
5 |
Advances in systemic treatment of malignant melanoma
|
Aapro, Matti S. |
|
1993 |
29 |
Supplement 1 |
p. 613-617 5 p. |
artikel |
6 |
A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium
|
Flemming Geertsen, Poul |
|
1993 |
29 |
Supplement 1 |
p. 347-350 4 p. |
artikel |
7 |
A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer
|
Levine, Mark N. |
|
1993 |
29 |
Supplement 1 |
p. 37-43 7 p. |
artikel |
8 |
Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy
|
Tilby, M.J. |
|
1993 |
29 |
Supplement 1 |
p. 681-686 6 p. |
artikel |
9 |
A randomised prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast cancer
|
Jeffry Evans, T.R. |
|
1993 |
29 |
Supplement 1 |
p. 316-319 4 p. |
artikel |
10 |
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer
|
Schor, A.M. |
|
1993 |
29 |
Supplement 1 |
p. 1141-1145 5 p. |
artikel |
11 |
A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours
|
Mousseau, M. |
|
1993 |
29 |
Supplement 1 |
p. 753-759 7 p. |
artikel |
12 |
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome
|
Montes, A. |
|
1993 |
29 |
Supplement 1 |
p. 1854-1857 4 p. |
artikel |
13 |
Bilateral testicular tumours: Prevalence and clinical implications
|
Bokemeyer, Carsten |
|
1993 |
29 |
Supplement 1 |
p. 874-876 3 p. |
artikel |
14 |
Biochemotherapy with dtic and thymosin-α1 (TA1) + interleukin-2 (IL-2) in patients (PTS) with metastatic melanoma (MM)
|
Carpano, S |
|
1993 |
29 |
Supplement 1 |
p. S182- 1 p. |
artikel |
15 |
Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens
|
Bartsch, H. |
|
1993 |
29 |
Supplement 1 |
p. 1199-1207 9 p. |
artikel |
16 |
Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation
|
Zoetmulder, F.A.N. |
|
1993 |
29 |
Supplement 1 |
p. 957-961 5 p. |
artikel |
17 |
CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastases
|
Bombardieri, Emilio |
|
1993 |
29 |
Supplement 1 |
p. 144-146 3 p. |
artikel |
18 |
Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer
|
Groen, H.J.M. |
|
1993 |
29 |
Supplement 1 |
p. 1696-1699 4 p. |
artikel |
19 |
Central small size breast cancer: How to overcome the problem of nipple and areola involvement
|
Galimberti, V. |
|
1993 |
29 |
Supplement 1 |
p. 1093-1096 4 p. |
artikel |
20 |
C-erbB-2/HER-2 protein in human intracranial tumours
|
Torp, Sverre Helge |
|
1993 |
29 |
Supplement 1 |
p. 1604-1606 3 p. |
artikel |
21 |
Childhood cancer incidence in the south-east of France
|
Bernard, Jean L. |
|
1993 |
29 |
Supplement 1 |
p. 2284-2291 8 p. |
artikel |
22 |
Childhood cancer mortality in the European Community, 1950–1989
|
Carmen Martos, M. |
|
1993 |
29 |
Supplement 1 |
p. 1783-1789 7 p. |
artikel |
23 |
Clinical hyperthermia
|
|
|
1993 |
29 |
Supplement 1 |
p. 1213- 1 p. |
artikel |
24 |
Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy
|
Andersson, Anders P. |
|
1993 |
29 |
Supplement 1 |
p. 1712-1714 3 p. |
artikel |
25 |
Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer
|
Bergman, Bengt |
|
1993 |
29 |
Supplement 1 |
p. 198-202 5 p. |
artikel |
26 |
Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck
|
Volling, Peter |
|
1993 |
29 |
Supplement 1 |
p. 383-389 7 p. |
artikel |
27 |
Combination chemoimmunotherapy for metastatic colorectal cancer using 5-fluorouracil, leucovorin and interleukin-2
|
Yang, James C. |
|
1993 |
29 |
Supplement 1 |
p. 355-359 5 p. |
artikel |
28 |
Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents
|
Gondal, Javed A |
|
1993 |
29 |
Supplement 1 |
p. 1536-1542 7 p. |
artikel |
29 |
Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney
|
Dewit, L. |
|
1993 |
29 |
Supplement 1 |
p. 2239-2243 5 p. |
artikel |
30 |
Continuous intravenous interleukin-2 infusion and subcutaneous interferon-α in metastatic renal cell carcinoma
|
Fosså, Sophie D. |
|
1993 |
29 |
Supplement 1 |
p. 1313-1315 3 p. |
artikel |
31 |
Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia
|
Braken, J.B. |
|
1993 |
29 |
Supplement 1 |
p. 515-518 4 p. |
artikel |
32 |
Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns
|
Merlo, Adrian |
|
1993 |
29 |
Supplement 1 |
p. 2118-2125 8 p. |
artikel |
33 |
[D-Arg1, D-Phe5, D-Trp7,9, Leu11]substance P inhibits the growth of human small cell lung cancer xenografts in vivo
|
Everard, Michele J. |
|
1993 |
29 |
Supplement 1 |
p. 1450-1453 4 p. |
artikel |
34 |
21-day schedule oral etoposide in children— a feasibility study
|
Davidson, A. |
|
1993 |
29 |
Supplement 1 |
p. 2223-2225 3 p. |
artikel |
35 |
Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts
|
Ruiz van Haperen, Veronique W.T. |
|
1993 |
29 |
Supplement 1 |
p. 2132-2137 6 p. |
artikel |
36 |
Detection of the multidrug resistance gene (MDR-1) expression by non-radioactive quantitative polymerase chain reaction
|
Lion, T. |
|
1993 |
29 |
Supplement 1 |
p. S114- 1 p. |
artikel |
37 |
Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: Results of three consecutive phase II studies
|
Bosset, J.F |
|
1993 |
29 |
Supplement 1 |
p. 1406-1410 5 p. |
artikel |
38 |
Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types
|
Schardt, Cordula |
|
1993 |
29 |
Supplement 1 |
p. 2250-2255 6 p. |
artikel |
39 |
Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6
|
Lennette, Evelyne T. |
|
1993 |
29 |
Supplement 1 |
p. 1584-1589 6 p. |
artikel |
40 |
DNA pattern and dietary habits in patients with breast cancer
|
Fürst, Carl Johan |
|
1993 |
29 |
Supplement 1 |
p. 1285-1288 4 p. |
artikel |
41 |
DNA: The double helix
|
|
|
1993 |
29 |
Supplement 1 |
p. 1213-1215 3 p. |
artikel |
42 |
Effect of d,l-verapamil, verapamil enantiomers and verapamil metabolites on the binding of vincristine to α1-acid glycoprotein
|
Woodcock, B.G. |
|
1993 |
29 |
Supplement 1 |
p. 559-561 3 p. |
artikel |
43 |
Effect of vinblastine (bolus versus split dose) on SA-1 ascitic tumor cells in mice
|
Serša, G |
|
1993 |
29 |
Supplement 1 |
p. S117- 1 p. |
artikel |
44 |
Evaluation of cyfra 21-1 as tumor marker at the diagnosis step in the primary lung cancer
|
Rastel, D. |
|
1993 |
29 |
Supplement 1 |
p. S243- 1 p. |
artikel |
45 |
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group
|
Kylmälä, T. |
|
1993 |
29 |
Supplement 1 |
p. 821-825 5 p. |
artikel |
46 |
Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (Vinfosiltine)
|
Fischel, J.L. |
|
1993 |
29 |
Supplement 1 |
p. 1890-1894 5 p. |
artikel |
47 |
Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinctive multiple drug-resistant phenotype in Chinese hamster ovary cells
|
McClean, Siobhán |
|
1993 |
29 |
Supplement 1 |
p. 2243-2248 6 p. |
artikel |
48 |
Experience with prevention of toxicity of taxotere in 1 ECTG centre
|
Schrijvers, D. |
|
1993 |
29 |
Supplement 1 |
p. S209- 1 p. |
artikel |
49 |
Expression of epithelial antigens EPM-1 and EXO-1 in normal, transitional, inflammatory and neoplastic colorectal mucosa
|
Klingel, R. |
|
1993 |
29 |
Supplement 1 |
p. 1723-1728 6 p. |
artikel |
50 |
Expression of MDR-1 and GSTII gene in human sarcomas
|
Cany, L |
|
1993 |
29 |
Supplement 1 |
p. S113- 1 p. |
artikel |
51 |
Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells
|
Mullen, Peter |
|
1993 |
29 |
Supplement 1 |
p. 248-252 5 p. |
artikel |
52 |
First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer
|
Bafaloukos, D. |
|
1993 |
29 |
Supplement 1 |
p. 851-853 3 p. |
artikel |
53 |
5-Fluorouracil (5FU) plus levdfolinic acid (1-FA) and hydroxyurea (HU) on a weekly schedule in the treatment of metastatic and/or recurrent colorectal adenocarcinoma (CA)
|
Gebbia, V |
|
1993 |
29 |
Supplement 1 |
p. S94- 1 p. |
artikel |
54 |
Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer
|
Louvet, Christophe |
|
1993 |
29 |
Supplement 1 |
p. 1835-1838 4 p. |
artikel |
55 |
Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients
|
Maiche, A.G |
|
1993 |
29 |
Supplement 1 |
p. 1403-1405 3 p. |
artikel |
56 |
Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy
|
Schmidberger, Heinz |
|
1993 |
29 |
Supplement 1 |
p. 1927-1931 5 p. |
artikel |
57 |
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours
|
Kattan, Joseph |
|
1993 |
29 |
Supplement 1 |
p. 1504-1509 6 p. |
artikel |
58 |
High rate of expression of multidrug resistance-associated P-glycoprotein in human endometrial carcinoma and normal endometrial tissue
|
Schneider, J. |
|
1993 |
29 |
Supplement 1 |
p. 554-558 5 p. |
artikel |
59 |
HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer
|
Glover, M.T. |
|
1993 |
29 |
Supplement 1 |
p. 520-524 5 p. |
artikel |
60 |
24-Hour plasma etoposide profile after oral and intravenous administration in children
|
Pinkerton, C.R. |
|
1993 |
29 |
Supplement 1 |
p. 1479-1481 3 p. |
artikel |
61 |
Human lung cancer: Alterations of parenchymal α1-adrenergic receptors
|
Kondratenko, T. |
|
1993 |
29 |
Supplement 1 |
p. S160- 1 p. |
artikel |
62 |
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours
|
Bartkova, Jirina |
|
1993 |
29 |
Supplement 1 |
p. 881-886 6 p. |
artikel |
63 |
Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: Relative prognostic value versus total cathepsin D
|
Brouillet, J.P. |
|
1993 |
29 |
Supplement 1 |
p. 1248-1251 4 p. |
artikel |
64 |
Increased chemosensitivity to doxorubicin of intrinsically multidrug-resistant human colon carcinoma cells by prolonged exposure to verapamil
|
Toffoli, Giuseppe |
|
1993 |
29 |
Supplement 1 |
p. 1776-1778 3 p. |
artikel |
65 |
In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment
|
Vitolo, Domenico |
|
1993 |
29 |
Supplement 1 |
p. 371-377 7 p. |
artikel |
66 |
Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines
|
Hofbauer, Susanne |
|
1993 |
29 |
Supplement 1 |
p. 241-245 5 p. |
artikel |
67 |
Intensive chemotherapy with fluorouracil, epirubicin, cyclophosphamide (FBC) day 1–8 in metastatic breast cancer
|
Bolognesi, A |
|
1993 |
29 |
Supplement 1 |
p. S85- 1 p. |
artikel |
68 |
Intermittent continuous intravenous infusion of 5-fluoruoracil; a useful approach in disseminated colorectal cancer?
|
Veenhof, C.H.N. |
|
1993 |
29 |
Supplement 1 |
p. 775- 1 p. |
artikel |
69 |
1. Introduction
|
|
|
1993 |
29 |
Supplement 1 |
p. S1-S4 4 p. |
artikel |
70 |
In vitro activity of the benzotriazene dioxide SR 4233 against human tumour colony-forming units
|
Hanauske, Axel-R. |
|
1993 |
29 |
Supplement 1 |
p. 423-425 3 p. |
artikel |
71 |
In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumours
|
Dietel, Manfred |
|
1993 |
29 |
Supplement 1 |
p. 416-420 5 p. |
artikel |
72 |
In vivo biological results of the association between interleukin-2 and interleukin-3 in the immunotherapy of cancer
|
Lissoni, P. |
|
1993 |
29 |
Supplement 1 |
p. 1127-1132 6 p. |
artikel |
73 |
Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases
|
Onier, Nathalie |
|
1993 |
29 |
Supplement 1 |
p. 2003-2009 7 p. |
artikel |
74 |
Karyotype in multiple myeloma and plasma cell leukaemia
|
Weh, Hans Josef |
|
1993 |
29 |
Supplement 1 |
p. 1269-1273 5 p. |
artikel |
75 |
Lipid-bound sialic acid, prostaglandin e and histamine in head and neck cancer
|
Klapan, Ivica |
|
1993 |
29 |
Supplement 1 |
p. 839-845 7 p. |
artikel |
76 |
Local response and long-term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder
|
deKernion, Jean B. |
|
1993 |
29 |
Supplement 1 |
p. 1223-1224 2 p. |
artikel |
77 |
MICE: a new active combination for non-small cell lung cancer
|
Arcangeli, Giuseppina |
|
1993 |
29 |
Supplement 1 |
p. 1848-1850 3 p. |
artikel |
78 |
Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study
|
Carmo-Pereira, J. |
|
1993 |
29 |
Supplement 1 |
p. 1814-1816 3 p. |
artikel |
79 |
Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and wellttolerated regimen for the treatment of advanced breast cancer
|
Wils, J.A. |
|
1993 |
29 |
Supplement 1 |
p. 2106-2108 3 p. |
artikel |
80 |
Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours
|
Wegmann, Barbara R |
|
1993 |
29 |
Supplement 1 |
p. 1578-1584 7 p. |
artikel |
81 |
5. Monitoring the programme and use of resources
|
|
|
1993 |
29 |
Supplement 1 |
p. S12-S16 5 p. |
artikel |
82 |
Neuroblastoma: A multiple biological disease
|
Tonini, Gian Paolo |
|
1993 |
29 |
Supplement 1 |
p. 802-804 3 p. |
artikel |
83 |
Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results
|
Lissoni, P |
|
1993 |
29 |
Supplement 1 |
p. 185-189 5 p. |
artikel |
84 |
New drugs for breast cancer
|
|
|
1993 |
29 |
Supplement 1 |
p. 1068- 1 p. |
artikel |
85 |
[No title]
|
Lennert, K. |
|
1993 |
29 |
Supplement 1 |
p. 913-914 2 p. |
artikel |
86 |
Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer
|
Fornander, Tommy |
|
1993 |
29 |
Supplement 1 |
p. 497-500 4 p. |
artikel |
87 |
Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy
|
Arpinelli, F. |
|
1993 |
29 |
Supplement 1 |
p. 651- 1 p. |
artikel |
88 |
Organisation of screening
|
Tubiana, Maurice |
|
1993 |
29 |
Supplement 1 |
p. 587-588 2 p. |
artikel |
89 |
Papers based on oral presentations at the symposium: Applications of recombinant human erythropoietin in cancer patients Florence, Italy, October 29, 1991
|
Calabresi, Federico |
|
1993 |
29 |
Supplement 1 |
p. S1- 1 p. |
artikel |
90 |
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients
|
de Forni, M. |
|
1993 |
29 |
Supplement 1 |
p. 983-988 6 p. |
artikel |
91 |
Phase I–II study of the addition of α-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of α-2a interferon and leucovorin
|
Sinnige, Harm A.M. |
|
1993 |
29 |
Supplement 1 |
p. 1715-1720 6 p. |
artikel |
92 |
Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer
|
Planting, A.S.T. |
|
1993 |
29 |
Supplement 1 |
p. 518-519 2 p. |
artikel |
93 |
Phase II study of elliptinium acetate salvage treatment of advanced breast cancer
|
Rouëssé, J. |
|
1993 |
29 |
Supplement 1 |
p. 856-859 4 p. |
artikel |
94 |
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC)
|
Chauvergne, J. |
|
1993 |
29 |
Supplement 1 |
p. 350-354 5 p. |
artikel |
95 |
Phase II study of weekly 4′-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: An EORTC Gynaecological Cancer Cooperative Group Study
|
van der Burg, M.E.L. |
|
1993 |
29 |
Supplement 1 |
p. 147-148 2 p. |
artikel |
96 |
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer
|
Gridelli, Cesare |
|
1993 |
29 |
Supplement 1 |
p. 1729-1731 3 p. |
artikel |
97 |
Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
|
Peyrat, J.P. |
|
1993 |
29 |
Supplement 1 |
p. 492-497 6 p. |
artikel |
98 |
Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells
|
Schwartz-Albiez, R. |
|
1993 |
29 |
Supplement 1 |
p. 1184-1189 6 p. |
artikel |
99 |
Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF
|
Kouri, Mauri |
|
1993 |
29 |
Supplement 1 |
p. 1691-1696 6 p. |
artikel |
100 |
Potentiation of EO9 anti-tumour activity by hydralazine
|
Bibby, Michael C. |
|
1993 |
29 |
Supplement 1 |
p. 1033-1035 3 p. |
artikel |
101 |
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications
|
Russo, P. |
|
1993 |
29 |
Supplement 1 |
p. 1157-1161 5 p. |
artikel |
102 |
Prad-1 gene amplification in head and neck squamous cell carcinoma
|
Klijanienko, J. |
|
1993 |
29 |
Supplement 1 |
p. S144- 1 p. |
artikel |
103 |
Pre and post operative values of cyfra 21-1, CEA, SCC, TPA and NSE in primary lung cancer
|
Rastel, D. |
|
1993 |
29 |
Supplement 1 |
p. S247- 1 p. |
artikel |
104 |
Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents
|
Vogel, M |
|
1993 |
29 |
Supplement 1 |
p. 2009-2014 6 p. |
artikel |
105 |
Prednimustine (sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer
|
Yosef, H. |
|
1993 |
29 |
Supplement 1 |
p. 1100-1105 6 p. |
artikel |
106 |
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma
|
Sweetenham, John W. |
|
1993 |
29 |
Supplement 1 |
p. 190-192 3 p. |
artikel |
107 |
Prevention
|
Ojasoo, T. |
|
1993 |
29 |
Supplement 1 |
p. 1071- 1 p. |
artikel |
108 |
Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy
|
Hachimi-Idrissi, S. |
|
1993 |
29 |
Supplement 1 |
p. 854-856 3 p. |
artikel |
109 |
Primary medical (neo-adjuvant) chemotherapy for operable breast cancer
|
Smith, Ian E. |
|
1993 |
29 |
Supplement 1 |
p. 1796-1799 4 p. |
artikel |
110 |
Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer
|
Schmitt, M. |
|
1993 |
29 |
Supplement 1 |
p. S31- 1 p. |
artikel |
111 |
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer
|
Bajetta, Emilio |
|
1993 |
29 |
Supplement 1 |
p. 1658-1663 6 p. |
artikel |
112 |
Pulmonary morbidity 10–18 years after irradiation for Hodgkin's disease
|
Hassink, Elly A.M. |
|
1993 |
29 |
Supplement 1 |
p. 343-347 5 p. |
artikel |
113 |
Quality of life assessment in a phase 1 study
|
Adams, L |
|
1993 |
29 |
Supplement 1 |
p. S259- 1 p. |
artikel |
114 |
Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)
|
Hollen, Patricia J. |
|
1993 |
29 |
Supplement 1 |
p. S51-S58 8 p. |
artikel |
115 |
Quality of life in breast cancer patients: The contribution of data to the care of patients
|
Meyerowitz, B.E. |
|
1993 |
29 |
Supplement 1 |
p. S59-S62 4 p. |
artikel |
116 |
Radioimmunoscintigraphy using [111In]antimyosin Fab fragments for the diagnosis and follow-up of rhabdomyosarcoma
|
Hoefnagel, C.A. |
|
1993 |
29 |
Supplement 1 |
p. 2096-2100 5 p. |
artikel |
117 |
Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer
|
Mori, Kiyoshi |
|
1993 |
29 |
Supplement 1 |
p. 677-680 4 p. |
artikel |
118 |
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer—A phase I toxicity study and pharmacokinetic analysis
|
Prendiville, J. |
|
1993 |
29 |
Supplement 1 |
p. 1700-1707 8 p. |
artikel |
119 |
Regional therapy of melanoma
|
Lejeune, F.J. |
|
1993 |
29 |
Supplement 1 |
p. 606-612 7 p. |
artikel |
120 |
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity
|
Nicholson, R.I. |
|
1993 |
29 |
Supplement 1 |
p. 1018-1023 6 p. |
artikel |
121 |
Response of a cancer registry to reports of disease clusters
|
King, Will D. |
|
1993 |
29 |
Supplement 1 |
p. 1414-1418 5 p. |
artikel |
122 |
Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb
|
Kroon, Bin B.R. |
|
1993 |
29 |
Supplement 1 |
p. 325-328 4 p. |
artikel |
123 |
Sarcomatoid tumours of the breast in Denmark from 1977 to 1987. A clinicopathological and immunohistochemical study of 100 cases
|
Christensen, Lise |
|
1993 |
29 |
Supplement 1 |
p. 1824-1831 8 p. |
artikel |
124 |
Sex hormones and anti-hormones
|
|
|
1993 |
29 |
Supplement 1 |
p. 648- 1 p. |
artikel |
125 |
Side-effects of GM-CSF treatment in advanced testicular cancer
|
Bokemeyer, Carsten |
|
1993 |
29 |
Supplement 1 |
p. 924- 1 p. |
artikel |
126 |
Side-effects of screening
|
Garstin, Ian W.H. |
|
1993 |
29 |
Supplement 1 |
p. 2150-2152 3 p. |
artikel |
127 |
Soluble intercellular adhesion molbcule 1 (sICAM-1) in various stages of breast cancer (BC)
|
Shapira, S |
|
1993 |
29 |
Supplement 1 |
p. S243- 1 p. |
artikel |
128 |
Steroid action symposium
|
|
|
1993 |
29 |
Supplement 1 |
p. 647- 1 p. |
artikel |
129 |
Study of the role of breast self-examination in the reduction of mortality from breast cancer
|
The Russian Federation/World Health Organization Study, |
|
1993 |
29 |
Supplement 1 |
p. 2039-2046 8 p. |
artikel |
130 |
Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy
|
Friedl, Andreas |
|
1993 |
29 |
Supplement 1 |
p. 1368-1372 5 p. |
artikel |
131 |
Surgical resection plus tamoxifen as treatment of breast cancer in elderly patients: a retrospective study
|
Martelli, Gabriele |
|
1993 |
29 |
Supplement 1 |
p. 2080-2082 3 p. |
artikel |
132 |
Surveillance following orchidectomy for stage I seminoma of the testis
|
von der Maase, Hans |
|
1993 |
29 |
Supplement 1 |
p. 1931-1934 4 p. |
artikel |
133 |
Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines
|
Fischel, J.L. |
|
1993 |
29 |
Supplement 1 |
p. 2269-2273 5 p. |
artikel |
134 |
Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
|
O'Reilly, S.M. |
|
1993 |
29 |
Supplement 1 |
p. 940-942 3 p. |
artikel |
135 |
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group
|
Postmus, Pieter E. |
|
1993 |
29 |
Supplement 1 |
p. 204-207 4 p. |
artikel |
136 |
The immunohistochemical detection of CSF-1 (colony stimulating factor-1) in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates
|
Scholl, S.M. |
|
1993 |
29 |
Supplement 1 |
p. S52- 1 p. |
artikel |
137 |
The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer
|
Langsteger, Werner |
|
1993 |
29 |
Supplement 1 |
p. 1547-1553 7 p. |
artikel |
138 |
The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients
|
Klijn, JGM |
|
1993 |
29 |
Supplement 1 |
p. S59- 1 p. |
artikel |
139 |
The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer
|
Cunningham, D. |
|
1993 |
29 |
Supplement 1 |
p. 303-306 4 p. |
artikel |
140 |
This article contains errors and has been withdrawn. A corrected version will be published in a later issue of volume 29 of the European journal of cancer
|
|
|
1993 |
29 |
Supplement 1 |
p. 592-595 4 p. |
artikel |
141 |
Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule
|
Satta, M.A. |
|
1993 |
29 |
Supplement 1 |
p. 1190-1192 3 p. |
artikel |
142 |
Tissue concentrations of prothymosin alpha: A novel proliferation index of primary breast cancer
|
Dominguez, Fernando |
|
1993 |
29 |
Supplement 1 |
p. 893-897 5 p. |
artikel |
143 |
Trends in neuroblastoma in Great Britain: Incidence and mortality, 1971–1990
|
Stiller, C.A. |
|
1993 |
29 |
Supplement 1 |
p. 1008-1012 5 p. |
artikel |
144 |
Tumour necrosis factor-α plasma levels after flavone acetic acid administration in man and mouse
|
Chabot, G.G. |
|
1993 |
29 |
Supplement 1 |
p. 729-733 5 p. |
artikel |
145 |
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells
|
Wiseman, Lynda R. |
|
1993 |
29 |
Supplement 1 |
p. 2256-2264 9 p. |
artikel |
146 |
Unexpected Prad-1 amplification in multiple simultaneous localisations of squamous cell carcinoma of the head and neck
|
Klijanienko, Jerzy |
|
1993 |
29 |
Supplement 1 |
p. 653-654 2 p. |
artikel |
147 |
Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex
|
Willemse, P.H.B. |
|
1993 |
29 |
Supplement 1 |
p. 359-362 4 p. |
artikel |